Article Correctness Is Author's Responsibility: NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

The article below may contain offensive and/or incorrect content.

This shows covid-19A phase 1 trial evaluating an investigational vaccine designed to protect against COVID-19 has begun in Seattle. The study will enroll 45 healthy people aged 18 to 55, over approximately 6 weeks. The first participant received the investigational vaccine today. Adults in the Seattle area may join the study.